Jefferies analyst Chris Howerton reiterated a Buy rating and $17 price target on Minerva Neurosciences (NASDAQ: NERV) as recent top-line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE